Jeffrey N. Simmons - 10 Mar 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role: PRESIDENT, CEO AND DIRECTOR, Director
Signature: /s/ Catherine S. Powell, as Attorney-in-Fact for Jeffrey N. Simmons
Issuer symbol: ELAN
Transactions as of: 10 Mar 2023
Net transactions value: +$143,972
Form type: 4
Filing time: 13 Mar 2023, 16:08:38 UTC
Previous filing: 07 Mar 2023
Next filing: 17 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELAN	Common Stock	Purchase	$143,972	+15,000	+50%	$9.60	45,000	10 Mar 2023	Revocable Trust	F1
holding	ELAN	Common Stock						1,142,569	10 Mar 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the weighted average price of 15,000 shares of common stock of Elanco Anima Health Inc. purchased by the reporting person in multiple transactions on March 10, 2023 with purchase prices ranging from $9.585 to $9.5999 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Content

Reflects the weighted average price of 15,000 shares of common stock of Elanco Anima Health Inc. purchased by the reporting person in multiple transactions on March 10, 2023 with purchase prices ranging from $9.585 to $9.5999 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.